HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin
Marco Biondini, Alexander Kiepas, Leeanna El–Houjeiri, Matthew G. Annis, Brian E. Hsu, Anne-Marie Fortier, Geneviève Morin, José A. Martina, Isabelle Sirois, Adriana Aguilar‐Mahecha, Tina Gruosso, Shawn McGuirk, April A. N. Rose, Ünal Metin Tokat, Radia Marie Johnson, Özgür Şahin, Eric Bareke, Julie St‐Pierre, Morag Park, Mark Basik, Jacek Majewski, Rosa Puertollano, Arnim Pause, Sidong Huang, Tibor Keler, Peter M. Siegel
Topics & Concepts
Cancer researchBiologyBreast cancerHsp90Heat shock proteinCancerPharmacologyInternal medicineMedicineBiochemistryGeneGeneticsHeat shock proteins researchCellular Mechanics and InteractionsWnt/β-catenin signaling in development and cancer